Fenofibrate Tablet
Product Images NDC 50268-338

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 50268-338). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20 (338 12)

Fenofibrate Tablets USP 48 mg oral tablets label from AvPAK. The label indicates Rx only and packaging contains 20 tablets (2 x 10 unit dose). It includes storage instructions and manufacturer details for AvKARE in Pulaski, TN. The label also features a barcode and the note New Appearance.*

FDA Label Image

Fenofibrate-molecular Structure (4c2fcac5 1c6c 40e2 Bbde 267c4aa2821f 01)

Chemical structure of fenofibrate showing its molecular arrangement with chlorophenyl and ester functional groups.*

FDA Label Image

4 (Table 4)

Table displaying the mean percent change in lipid parameters at the end of treatment, comparing fenofibrate (FEN) and placebo groups across pooled cohorts and subgroups based on baseline LDL-C and triglyceride levels. Parameters include Total-C, LDL-C, HDL-C, and triglycerides (TG), with data reflecting mean baseline values and percentage changes in different treatment groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.